PROCEPT BioRobotics CorporationPRCTNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +56.57% | +55.28% | +48.41% | +42.76% | +11.94% |
| Gross Profit Growth | +105.47% | +76.40% | +64.37% | +46.31% | +6.05% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +6.42% | +7.66% | +7.41% | +7.14% | +3.51% |
| Weighted Average Shares Diluted Growth | +6.42% | +7.66% | +7.41% | +7.14% | +3.51% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +72.60% | +41.34% | +37.17% | +22.38% | +0.04% |
| Inventory Growth | +41.28% | +49.75% | +52.81% | +31.20% | +25.86% |
| Asset Growth | +31.95% | +35.64% | +37.05% | +36.72% | -4.86% |
| Book Value per Share Growth | +34.62% | +36.90% | +42.66% | +47.14% | -12.12% |
| Debt Growth | +1.32% | -1.93% | -2.04% | -2.12% | -35.68% |
| R&D Expense Growth | +3.93% | +25.36% | +0.75% | +9.25% | +26.48% |
| SG&A Expenses Growth | +33.04% | +39.39% | +37.97% | +38.23% | +20.66% |